BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.01B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$175M |
| 4 |
Merck
MRK
|
+$138M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$949M |
| 2 |
Bank of America
BAC
|
+$275M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$208M |
| 4 |
Canadian National Railway
CNI
|
+$154M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.39% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Industrials | 6% |
| 5 | Healthcare | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Synopsys
SNPS
$80.7B
| $84.7K | ﹤0.01% |
1,672
-3,865
| -70% | -$188K |
|
|
ARRY
2127
DELISTED
Array Biopharma Inc
ARRY
| $84.6K | ﹤0.01% |
11,735
+8,423
| +254% | +$62.2K |
|
2128
Safety Insurance
SAFT
$1.52B
| $84.5K | ﹤0.01% |
1,465
+1,154
| +371% | +$66.9K |
|
|
NAVG
2129
DELISTED
Navigators Group Inc
NAVG
| $84.5K | ﹤0.01% |
2,180
+1,690
| +345% | +$66.1K |
|
|
IPCC
2130
DELISTED
Infinity Property & Casualty C
IPCC
| $84K | ﹤0.01% |
1,108
+832
| +301% | +$63.1K |
|
2131
TFS Financial
TFSL
$4.95B
| $83.9K | ﹤0.01% |
4,991
+29
| +0.6% | +$436 |
|
|
BSFT
2132
DELISTED
BroadSoft, Inc.
BSFT
| $83.8K | ﹤0.01% |
2,425
+1,754
| +261% | +$62.1K |
|
2133
Mercury Insurance
MCY
$5.84B
| $83.8K | ﹤0.01% |
1,506
-768
| -34% | -$43.3K |
|
2134
Acco Brands
ACCO
$401M
| $83.8K | ﹤0.01% |
10,785
+8,090
| +300% | +$63.6K |
|
2135
Greif
GEF
$4.97B
| $83.8K | ﹤0.01% |
2,337
+1,309
| +127% | +$52K |
|
|
RP
2136
DELISTED
RealPage, Inc.
RP
| $83.7K | ﹤0.01% |
4,391
+3,167
| +259% | +$61.3K |
|
|
SAGE
2137
DELISTED
Sage Therapeutics
SAGE
| $83.7K | ﹤0.01% |
1,147
+1,016
| +776% | +$65.3K |
|
2138
Globalstar
GSAT
$10.7B
| $83.6K | ﹤0.01% |
2,641
+2,207
| +509% | +$85.8K |
|
2139
Qualys
QLYS
$6.44B
| $83.4K | ﹤0.01% |
2,067
+1,595
| +338% | +$71.6K |
|
2140
Emergent Biosolutions
EBS
$235M
| $83.2K | ﹤0.01% |
2,525
+1,825
| +261% | +$56.6K |
|
2141
TherapeuticsMD
TXMD
$24M
| $83.1K | ﹤0.01% |
211
+155
| +277% | +$54.7K |
|
2142
AMERISAFE
AMSF
$513M
| $83.1K | ﹤0.01% |
1,766
+1,327
| +302% | +$59.8K |
|
|
WIRE
2143
DELISTED
Encore Wire Corp
WIRE
| $83K | ﹤0.01% |
1,875
+1,377
| +277% | +$59.8K |
|
|
BGG
2144
DELISTED
Briggs & Stratton Corp.
BGG
| $82.7K | ﹤0.01% |
4,294
+3,194
| +290% | +$62.5K |
|
2145
TETRA Technologies
TTI
$1.27B
| $82.4K | ﹤0.01% |
12,921
-7,229
| -36% | -$48.8K |
|
|
ARR
2146
Armour Residential REIT
ARR
$2.37B
| $82.4K | ﹤0.01% |
733
+310
| +73% | +$37.7K |
|
2147
Gray Television
GTN
$538M
| $82.4K | ﹤0.01% |
5,252
+4,077
| +347% | +$59.8K |
|
2148
Helios Technologies
HLIO
$2.69B
| $82.2K | ﹤0.01% |
2,158
+1,632
| +310% | +$63.3K |
|
2149
Expro Ltd
XPRO
$2.1B
| $82.1K | ﹤0.01% |
726
+601
| +481% | +$71.5K |
|
2150
KT
KT
$9.11B
| $82K | ﹤0.01% |
6,472
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q2 2015 Portfolio in Review
As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
- BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
- BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
- BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.